nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—Didanosine—acquired immunodeficiency syndrome	0.282	0.656	CrCtD
Zalcitabine—Lamivudine—acquired immunodeficiency syndrome	0.148	0.344	CrCtD
Zalcitabine—Emtricitabine—Lamivudine—acquired immunodeficiency syndrome	0.0865	0.4	CrCrCtD
Zalcitabine—Gemcitabine—Lamivudine—acquired immunodeficiency syndrome	0.0723	0.335	CrCrCtD
Zalcitabine—SLC29A2—Didanosine—acquired immunodeficiency syndrome	0.0654	0.237	CbGbCtD
Zalcitabine—SLC29A1—Didanosine—acquired immunodeficiency syndrome	0.0375	0.136	CbGbCtD
Zalcitabine—SLC29A2—Zidovudine—acquired immunodeficiency syndrome	0.0343	0.125	CbGbCtD
Zalcitabine—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.03	0.139	CrCrCtD
Zalcitabine—Decitabine—Lamivudine—acquired immunodeficiency syndrome	0.0272	0.126	CrCrCtD
Zalcitabine—DCK—Lamivudine—acquired immunodeficiency syndrome	0.0141	0.0513	CbGbCtD
Zalcitabine—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.00792	0.0287	CbGbCtD
Zalcitabine—SLC22A7—Zidovudine—acquired immunodeficiency syndrome	0.00741	0.0269	CbGbCtD
Zalcitabine—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.006	0.0218	CbGbCtD
Zalcitabine—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.00396	0.0144	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.00396	0.0144	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.00342	0.0124	CbGbCtD
Zalcitabine—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.00342	0.0124	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.00332	0.012	CbGbCtD
Zalcitabine—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.00332	0.012	CbGbCtD
Zalcitabine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00328	0.0119	CbGbCtD
Zalcitabine—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.00315	0.0114	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.003	0.0109	CbGbCtD
Zalcitabine—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.003	0.0109	CbGbCtD
Zalcitabine—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.003	0.0109	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.003	0.0109	CbGbCtD
Zalcitabine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00297	0.0108	CbGbCtD
Zalcitabine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00297	0.0108	CbGbCtD
Zalcitabine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00256	0.0093	CbGbCtD
Zalcitabine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00249	0.00903	CbGbCtD
Zalcitabine—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.00244	0.00885	CbGbCtD
Zalcitabine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00234	0.0085	CbGbCtD
Zalcitabine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00225	0.00817	CbGbCtD
Zalcitabine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00225	0.00817	CbGbCtD
Zalcitabine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0022	0.00799	CbGbCtD
Zalcitabine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0022	0.00799	CbGbCtD
Zalcitabine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00214	0.00777	CbGbCtD
Zalcitabine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00201	0.00731	CbGbCtD
Zalcitabine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00201	0.00731	CbGbCtD
Zalcitabine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00199	0.00723	CbGbCtD
Zalcitabine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00199	0.00723	CbGbCtD
Zalcitabine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00182	0.00661	CbGbCtD
Zalcitabine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00182	0.00661	CbGbCtD
Zalcitabine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00172	0.00624	CbGbCtD
Zalcitabine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00167	0.00606	CbGbCtD
Zalcitabine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00157	0.0057	CbGbCtD
Zalcitabine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00153	0.00554	CbGbCtD
Zalcitabine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00151	0.00548	CbGbCtD
Zalcitabine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00151	0.00548	CbGbCtD
Zalcitabine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00145	0.00525	CbGbCtD
Zalcitabine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00501	CbGbCtD
Zalcitabine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00138	0.00501	CbGbCtD
Zalcitabine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.00494	CbGbCtD
Zalcitabine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00128	0.00465	CbGbCtD
Zalcitabine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00128	0.00465	CbGbCtD
Zalcitabine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00116	0.0042	CbGbCtD
Zalcitabine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00116	0.0042	CbGbCtD
Zalcitabine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.000999	0.00363	CbGbCtD
Zalcitabine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00097	0.00352	CbGbCtD
Zalcitabine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.000877	0.00318	CbGbCtD
Zalcitabine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.000877	0.00318	CbGbCtD
Zalcitabine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.000841	0.00305	CbGbCtD
Zalcitabine—SLC29A2—blood—acquired immunodeficiency syndrome	0.00038	0.0515	CbGeAlD
Zalcitabine—SLC29A2—vagina—acquired immunodeficiency syndrome	0.000353	0.0478	CbGeAlD
Zalcitabine—DCK—retina—acquired immunodeficiency syndrome	0.000269	0.0365	CbGeAlD
Zalcitabine—SLC22A7—digestive system—acquired immunodeficiency syndrome	0.000257	0.0347	CbGeAlD
Zalcitabine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000255	0.0345	CbGeAlD
Zalcitabine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000251	0.0339	CbGeAlD
Zalcitabine—SLC29A2—brain—acquired immunodeficiency syndrome	0.000236	0.032	CbGeAlD
Zalcitabine—SLC29A2—lymph node—acquired immunodeficiency syndrome	0.000228	0.0309	CbGeAlD
Zalcitabine—SLC29A1—lymphoid tissue—acquired immunodeficiency syndrome	0.0002	0.0271	CbGeAlD
Zalcitabine—SLC29A1—digestive system—acquired immunodeficiency syndrome	0.000198	0.0268	CbGeAlD
Zalcitabine—DCK—lymphoid tissue—acquired immunodeficiency syndrome	0.000191	0.0259	CbGeAlD
Zalcitabine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000191	0.0259	CbGeAlD
Zalcitabine—DCK—digestive system—acquired immunodeficiency syndrome	0.000189	0.0256	CbGeAlD
Zalcitabine—SLC29A1—blood—acquired immunodeficiency syndrome	0.000189	0.0255	CbGeAlD
Zalcitabine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000188	0.0255	CbGeAlD
Zalcitabine—SLC29A1—bone marrow—acquired immunodeficiency syndrome	0.000182	0.0247	CbGeAlD
Zalcitabine—DCK—blood—acquired immunodeficiency syndrome	0.00018	0.0244	CbGeAlD
Zalcitabine—SLC29A1—vagina—acquired immunodeficiency syndrome	0.000175	0.0237	CbGeAlD
Zalcitabine—DCK—bone marrow—acquired immunodeficiency syndrome	0.000174	0.0236	CbGeAlD
Zalcitabine—DCK—spinal cord—acquired immunodeficiency syndrome	0.000174	0.0235	CbGeAlD
Zalcitabine—DCK—vagina—acquired immunodeficiency syndrome	0.000167	0.0226	CbGeAlD
Zalcitabine—SLC29A1—lung—acquired immunodeficiency syndrome	0.000165	0.0224	CbGeAlD
Zalcitabine—DCK—lung—acquired immunodeficiency syndrome	0.000158	0.0214	CbGeAlD
Zalcitabine—SLC29A1—nervous system—acquired immunodeficiency syndrome	0.000153	0.0207	CbGeAlD
Zalcitabine—SLC22A7—brain—acquired immunodeficiency syndrome	0.000152	0.0205	CbGeAlD
Zalcitabine—SLC29A1—central nervous system—acquired immunodeficiency syndrome	0.000147	0.02	CbGeAlD
Zalcitabine—SLC22A6—brain—acquired immunodeficiency syndrome	0.000146	0.0198	CbGeAlD
Zalcitabine—DCK—nervous system—acquired immunodeficiency syndrome	0.000146	0.0198	CbGeAlD
Zalcitabine—DCK—central nervous system—acquired immunodeficiency syndrome	0.000141	0.0191	CbGeAlD
Zalcitabine—SLC29A1—brain—acquired immunodeficiency syndrome	0.000117	0.0159	CbGeAlD
Zalcitabine—SLC29A1—lymph node—acquired immunodeficiency syndrome	0.000113	0.0153	CbGeAlD
Zalcitabine—DCK—brain—acquired immunodeficiency syndrome	0.000112	0.0151	CbGeAlD
Zalcitabine—DCK—lymph node—acquired immunodeficiency syndrome	0.000108	0.0146	CbGeAlD
Zalcitabine—CYP3A5—digestive system—acquired immunodeficiency syndrome	9.79e-05	0.0133	CbGeAlD
Zalcitabine—CYP2C9—digestive system—acquired immunodeficiency syndrome	9.64e-05	0.0131	CbGeAlD
Zalcitabine—CYP3A5—blood—acquired immunodeficiency syndrome	9.33e-05	0.0126	CbGeAlD
Zalcitabine—CYP2C9—blood—acquired immunodeficiency syndrome	9.18e-05	0.0124	CbGeAlD
Zalcitabine—CYP3A5—vagina—acquired immunodeficiency syndrome	8.65e-05	0.0117	CbGeAlD
Zalcitabine—CYP3A5—lung—acquired immunodeficiency syndrome	8.18e-05	0.0111	CbGeAlD
Zalcitabine—CYP3A4—digestive system—acquired immunodeficiency syndrome	7.35e-05	0.00995	CbGeAlD
Zalcitabine—CYP2D6—digestive system—acquired immunodeficiency syndrome	7.23e-05	0.0098	CbGeAlD
Zalcitabine—CYP3A4—blood—acquired immunodeficiency syndrome	7e-05	0.00948	CbGeAlD
Zalcitabine—CYP2D6—blood—acquired immunodeficiency syndrome	6.89e-05	0.00933	CbGeAlD
Zalcitabine—CYP3A4—nervous system—acquired immunodeficiency syndrome	5.68e-05	0.0077	CbGeAlD
Zalcitabine—CYP2D6—nervous system—acquired immunodeficiency syndrome	5.59e-05	0.00758	CbGeAlD
Zalcitabine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	5.47e-05	0.00741	CbGeAlD
Zalcitabine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	5.39e-05	0.00729	CbGeAlD
Zalcitabine—CYP2D6—brain—acquired immunodeficiency syndrome	4.28e-05	0.00579	CbGeAlD
Zalcitabine—Agitation—Saquinavir—acquired immunodeficiency syndrome	2.41e-05	0.000337	CcSEcCtD
Zalcitabine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	2.41e-05	0.000337	CcSEcCtD
Zalcitabine—Insomnia—Indinavir—acquired immunodeficiency syndrome	2.41e-05	0.000337	CcSEcCtD
Zalcitabine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	2.41e-05	0.000337	CcSEcCtD
Zalcitabine—Oedema—Delavirdine—acquired immunodeficiency syndrome	2.41e-05	0.000336	CcSEcCtD
Zalcitabine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	2.4e-05	0.000335	CcSEcCtD
Zalcitabine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	2.4e-05	0.000335	CcSEcCtD
Zalcitabine—Rash—Didanosine—acquired immunodeficiency syndrome	2.39e-05	0.000334	CcSEcCtD
Zalcitabine—Infection—Delavirdine—acquired immunodeficiency syndrome	2.39e-05	0.000334	CcSEcCtD
Zalcitabine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	2.39e-05	0.000334	CcSEcCtD
Zalcitabine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	2.39e-05	0.000334	CcSEcCtD
Zalcitabine—Cough—Ritonavir—acquired immunodeficiency syndrome	2.38e-05	0.000333	CcSEcCtD
Zalcitabine—Headache—Didanosine—acquired immunodeficiency syndrome	2.38e-05	0.000332	CcSEcCtD
Zalcitabine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	2.38e-05	0.000332	CcSEcCtD
Zalcitabine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	2.37e-05	0.000331	CcSEcCtD
Zalcitabine—Shock—Delavirdine—acquired immunodeficiency syndrome	2.37e-05	0.000331	CcSEcCtD
Zalcitabine—Malaise—Saquinavir—acquired immunodeficiency syndrome	2.37e-05	0.000331	CcSEcCtD
Zalcitabine—Somnolence—Indinavir—acquired immunodeficiency syndrome	2.37e-05	0.000331	CcSEcCtD
Zalcitabine—Asthenia—Stavudine—acquired immunodeficiency syndrome	2.37e-05	0.00033	CcSEcCtD
Zalcitabine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	2.37e-05	0.00033	CcSEcCtD
Zalcitabine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	2.36e-05	0.00033	CcSEcCtD
Zalcitabine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	2.36e-05	0.00033	CcSEcCtD
Zalcitabine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	2.36e-05	0.000329	CcSEcCtD
Zalcitabine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	2.36e-05	0.000329	CcSEcCtD
Zalcitabine—Syncope—Saquinavir—acquired immunodeficiency syndrome	2.36e-05	0.000329	CcSEcCtD
Zalcitabine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	2.35e-05	0.000328	CcSEcCtD
Zalcitabine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	2.35e-05	0.000328	CcSEcCtD
Zalcitabine—Tremor—Lamivudine—acquired immunodeficiency syndrome	2.35e-05	0.000328	CcSEcCtD
Zalcitabine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	2.35e-05	0.000328	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	2.34e-05	0.000327	CcSEcCtD
Zalcitabine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	2.34e-05	0.000327	CcSEcCtD
Zalcitabine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	2.34e-05	0.000327	CcSEcCtD
Zalcitabine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	2.34e-05	0.000326	CcSEcCtD
Zalcitabine—Pruritus—Stavudine—acquired immunodeficiency syndrome	2.33e-05	0.000326	CcSEcCtD
Zalcitabine—Asthenia—Abacavir—acquired immunodeficiency syndrome	2.33e-05	0.000325	CcSEcCtD
Zalcitabine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	2.33e-05	0.000325	CcSEcCtD
Zalcitabine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	2.33e-05	0.000325	CcSEcCtD
Zalcitabine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	2.32e-05	0.000325	CcSEcCtD
Zalcitabine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	2.32e-05	0.000325	CcSEcCtD
Zalcitabine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	2.32e-05	0.000324	CcSEcCtD
Zalcitabine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	2.32e-05	0.000324	CcSEcCtD
Zalcitabine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	2.32e-05	0.000323	CcSEcCtD
Zalcitabine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	2.31e-05	0.000322	CcSEcCtD
Zalcitabine—Pruritus—Abacavir—acquired immunodeficiency syndrome	2.3e-05	0.000321	CcSEcCtD
Zalcitabine—Fatigue—Indinavir—acquired immunodeficiency syndrome	2.3e-05	0.000321	CcSEcCtD
Zalcitabine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	2.3e-05	0.000321	CcSEcCtD
Zalcitabine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	2.3e-05	0.000321	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	2.29e-05	0.00032	CcSEcCtD
Zalcitabine—Cough—Saquinavir—acquired immunodeficiency syndrome	2.29e-05	0.00032	CcSEcCtD
Zalcitabine—Pain—Indinavir—acquired immunodeficiency syndrome	2.28e-05	0.000318	CcSEcCtD
Zalcitabine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	2.28e-05	0.000318	CcSEcCtD
Zalcitabine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	2.28e-05	0.000318	CcSEcCtD
Zalcitabine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	2.28e-05	0.000318	CcSEcCtD
Zalcitabine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	2.27e-05	0.000317	CcSEcCtD
Zalcitabine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	2.27e-05	0.000317	CcSEcCtD
Zalcitabine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	2.27e-05	0.000316	CcSEcCtD
Zalcitabine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	2.27e-05	0.000316	CcSEcCtD
Zalcitabine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	2.26e-05	0.000316	CcSEcCtD
Zalcitabine—Malaise—Lamivudine—acquired immunodeficiency syndrome	2.26e-05	0.000316	CcSEcCtD
Zalcitabine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	2.26e-05	0.000315	CcSEcCtD
Zalcitabine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	2.25e-05	0.000314	CcSEcCtD
Zalcitabine—Syncope—Lamivudine—acquired immunodeficiency syndrome	2.25e-05	0.000314	CcSEcCtD
Zalcitabine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	2.25e-05	0.000314	CcSEcCtD
Zalcitabine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	2.25e-05	0.000313	CcSEcCtD
Zalcitabine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	2.24e-05	0.000313	CcSEcCtD
Zalcitabine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	2.24e-05	0.000313	CcSEcCtD
Zalcitabine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	2.24e-05	0.000312	CcSEcCtD
Zalcitabine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	2.24e-05	0.000312	CcSEcCtD
Zalcitabine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	2.23e-05	0.000311	CcSEcCtD
Zalcitabine—Oedema—Ritonavir—acquired immunodeficiency syndrome	2.23e-05	0.000311	CcSEcCtD
Zalcitabine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	2.22e-05	0.00031	CcSEcCtD
Zalcitabine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	2.22e-05	0.00031	CcSEcCtD
Zalcitabine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	2.21e-05	0.000309	CcSEcCtD
Zalcitabine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	2.2e-05	0.000308	CcSEcCtD
Zalcitabine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	2.2e-05	0.000307	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	2.2e-05	0.000307	CcSEcCtD
Zalcitabine—Shock—Ritonavir—acquired immunodeficiency syndrome	2.19e-05	0.000306	CcSEcCtD
Zalcitabine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	2.19e-05	0.000306	CcSEcCtD
Zalcitabine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	2.19e-05	0.000306	CcSEcCtD
Zalcitabine—Cough—Lamivudine—acquired immunodeficiency syndrome	2.19e-05	0.000305	CcSEcCtD
Zalcitabine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	2.19e-05	0.000305	CcSEcCtD
Zalcitabine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	2.18e-05	0.000305	CcSEcCtD
Zalcitabine—Dizziness—Stavudine—acquired immunodeficiency syndrome	2.18e-05	0.000304	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	2.18e-05	0.000304	CcSEcCtD
Zalcitabine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	2.18e-05	0.000304	CcSEcCtD
Zalcitabine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	2.17e-05	0.000304	CcSEcCtD
Zalcitabine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	2.17e-05	0.000303	CcSEcCtD
Zalcitabine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	2.17e-05	0.000303	CcSEcCtD
Zalcitabine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	2.17e-05	0.000303	CcSEcCtD
Zalcitabine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	2.16e-05	0.000302	CcSEcCtD
Zalcitabine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	2.16e-05	0.000302	CcSEcCtD
Zalcitabine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	2.15e-05	0.000301	CcSEcCtD
Zalcitabine—Pain—Efavirenz—acquired immunodeficiency syndrome	2.15e-05	0.000301	CcSEcCtD
Zalcitabine—Rash—Nevirapine—acquired immunodeficiency syndrome	2.15e-05	0.000301	CcSEcCtD
Zalcitabine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	2.15e-05	0.0003	CcSEcCtD
Zalcitabine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	2.15e-05	0.0003	CcSEcCtD
Zalcitabine—Dizziness—Abacavir—acquired immunodeficiency syndrome	2.15e-05	0.0003	CcSEcCtD
Zalcitabine—Oedema—Saquinavir—acquired immunodeficiency syndrome	2.14e-05	0.000299	CcSEcCtD
Zalcitabine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	2.14e-05	0.000299	CcSEcCtD
Zalcitabine—Headache—Nevirapine—acquired immunodeficiency syndrome	2.14e-05	0.000299	CcSEcCtD
Zalcitabine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	2.13e-05	0.000298	CcSEcCtD
Zalcitabine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	2.13e-05	0.000298	CcSEcCtD
Zalcitabine—Infection—Saquinavir—acquired immunodeficiency syndrome	2.13e-05	0.000297	CcSEcCtD
Zalcitabine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	2.13e-05	0.000297	CcSEcCtD
Zalcitabine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	2.12e-05	0.000297	CcSEcCtD
Zalcitabine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	2.12e-05	0.000296	CcSEcCtD
Zalcitabine—Urticaria—Indinavir—acquired immunodeficiency syndrome	2.12e-05	0.000296	CcSEcCtD
Zalcitabine—Shock—Saquinavir—acquired immunodeficiency syndrome	2.11e-05	0.000295	CcSEcCtD
Zalcitabine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	2.11e-05	0.000294	CcSEcCtD
Zalcitabine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	2.11e-05	0.000294	CcSEcCtD
Zalcitabine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	2.11e-05	0.000294	CcSEcCtD
Zalcitabine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	2.1e-05	0.000294	CcSEcCtD
Zalcitabine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	2.1e-05	0.000293	CcSEcCtD
Zalcitabine—Vomiting—Stavudine—acquired immunodeficiency syndrome	2.1e-05	0.000293	CcSEcCtD
Zalcitabine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	2.09e-05	0.000292	CcSEcCtD
Zalcitabine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	2.09e-05	0.000291	CcSEcCtD
Zalcitabine—Rash—Nelfinavir—acquired immunodeficiency syndrome	2.09e-05	0.000291	CcSEcCtD
Zalcitabine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	2.08e-05	0.000291	CcSEcCtD
Zalcitabine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	2.08e-05	0.000291	CcSEcCtD
Zalcitabine—Rash—Stavudine—acquired immunodeficiency syndrome	2.08e-05	0.00029	CcSEcCtD
Zalcitabine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	2.08e-05	0.00029	CcSEcCtD
Zalcitabine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	2.08e-05	0.00029	CcSEcCtD
Zalcitabine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	2.08e-05	0.00029	CcSEcCtD
Zalcitabine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	2.07e-05	0.000289	CcSEcCtD
Zalcitabine—Headache—Nelfinavir—acquired immunodeficiency syndrome	2.07e-05	0.000289	CcSEcCtD
Zalcitabine—Headache—Stavudine—acquired immunodeficiency syndrome	2.07e-05	0.000288	CcSEcCtD
Zalcitabine—Vomiting—Abacavir—acquired immunodeficiency syndrome	2.07e-05	0.000288	CcSEcCtD
Zalcitabine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	2.06e-05	0.000288	CcSEcCtD
Zalcitabine—Pain—Delavirdine—acquired immunodeficiency syndrome	2.06e-05	0.000288	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	2.06e-05	0.000288	CcSEcCtD
Zalcitabine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	2.06e-05	0.000287	CcSEcCtD
Zalcitabine—Rash—Abacavir—acquired immunodeficiency syndrome	2.05e-05	0.000286	CcSEcCtD
Zalcitabine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	2.05e-05	0.000286	CcSEcCtD
Zalcitabine—Oedema—Lamivudine—acquired immunodeficiency syndrome	2.05e-05	0.000286	CcSEcCtD
Zalcitabine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	2.04e-05	0.000285	CcSEcCtD
Zalcitabine—Headache—Abacavir—acquired immunodeficiency syndrome	2.04e-05	0.000284	CcSEcCtD
Zalcitabine—Infection—Lamivudine—acquired immunodeficiency syndrome	2.03e-05	0.000284	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	2.03e-05	0.000283	CcSEcCtD
Zalcitabine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	2.03e-05	0.000283	CcSEcCtD
Zalcitabine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	2.02e-05	0.000281	CcSEcCtD
Zalcitabine—Shock—Lamivudine—acquired immunodeficiency syndrome	2.01e-05	0.000281	CcSEcCtD
Zalcitabine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	2e-05	0.00028	CcSEcCtD
Zalcitabine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	2e-05	0.000279	CcSEcCtD
Zalcitabine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	1.99e-05	0.000278	CcSEcCtD
Zalcitabine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	1.99e-05	0.000278	CcSEcCtD
Zalcitabine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	1.99e-05	0.000277	CcSEcCtD
Zalcitabine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	1.99e-05	0.000277	CcSEcCtD
Zalcitabine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	1.99e-05	0.000277	CcSEcCtD
Zalcitabine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	1.98e-05	0.000277	CcSEcCtD
Zalcitabine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	1.98e-05	0.000276	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	1.97e-05	0.000275	CcSEcCtD
Zalcitabine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	1.96e-05	0.000274	CcSEcCtD
Zalcitabine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	1.96e-05	0.000274	CcSEcCtD
Zalcitabine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	1.96e-05	0.000274	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	1.95e-05	0.000273	CcSEcCtD
Zalcitabine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	1.95e-05	0.000272	CcSEcCtD
Zalcitabine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	1.94e-05	0.000271	CcSEcCtD
Zalcitabine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	1.94e-05	0.00027	CcSEcCtD
Zalcitabine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	1.92e-05	0.000268	CcSEcCtD
Zalcitabine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	1.91e-05	0.000267	CcSEcCtD
Zalcitabine—Asthenia—Indinavir—acquired immunodeficiency syndrome	1.91e-05	0.000267	CcSEcCtD
Zalcitabine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	1.91e-05	0.000267	CcSEcCtD
Zalcitabine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	1.91e-05	0.000266	CcSEcCtD
Zalcitabine—Pain—Ritonavir—acquired immunodeficiency syndrome	1.91e-05	0.000266	CcSEcCtD
Zalcitabine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	1.9e-05	0.000266	CcSEcCtD
Zalcitabine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	1.9e-05	0.000266	CcSEcCtD
Zalcitabine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	1.9e-05	0.000265	CcSEcCtD
Zalcitabine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	1.89e-05	0.000264	CcSEcCtD
Zalcitabine—Pruritus—Indinavir—acquired immunodeficiency syndrome	1.89e-05	0.000263	CcSEcCtD
Zalcitabine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	1.86e-05	0.00026	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	1.86e-05	0.00026	CcSEcCtD
Zalcitabine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	1.86e-05	0.000259	CcSEcCtD
Zalcitabine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	1.85e-05	0.000258	CcSEcCtD
Zalcitabine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	1.85e-05	0.000258	CcSEcCtD
Zalcitabine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	1.84e-05	0.000256	CcSEcCtD
Zalcitabine—Pain—Saquinavir—acquired immunodeficiency syndrome	1.83e-05	0.000256	CcSEcCtD
Zalcitabine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000255	CcSEcCtD
Zalcitabine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	1.82e-05	0.000255	CcSEcCtD
Zalcitabine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	1.82e-05	0.000254	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	1.82e-05	0.000254	CcSEcCtD
Zalcitabine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000254	CcSEcCtD
Zalcitabine—Rash—Zidovudine—acquired immunodeficiency syndrome	1.81e-05	0.000252	CcSEcCtD
Zalcitabine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	1.81e-05	0.000252	CcSEcCtD
Zalcitabine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	1.81e-05	0.000252	CcSEcCtD
Zalcitabine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	1.8e-05	0.000251	CcSEcCtD
Zalcitabine—Headache—Zidovudine—acquired immunodeficiency syndrome	1.8e-05	0.000251	CcSEcCtD
Zalcitabine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	1.78e-05	0.000249	CcSEcCtD
Zalcitabine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	1.78e-05	0.000248	CcSEcCtD
Zalcitabine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	1.78e-05	0.000248	CcSEcCtD
Zalcitabine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	1.77e-05	0.000247	CcSEcCtD
Zalcitabine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	1.77e-05	0.000247	CcSEcCtD
Zalcitabine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	1.76e-05	0.000246	CcSEcCtD
Zalcitabine—Dizziness—Indinavir—acquired immunodeficiency syndrome	1.76e-05	0.000246	CcSEcCtD
Zalcitabine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	1.76e-05	0.000246	CcSEcCtD
Zalcitabine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	1.76e-05	0.000246	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	1.75e-05	0.000245	CcSEcCtD
Zalcitabine—Pain—Lamivudine—acquired immunodeficiency syndrome	1.75e-05	0.000244	CcSEcCtD
Zalcitabine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	1.73e-05	0.000241	CcSEcCtD
Zalcitabine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	1.72e-05	0.000241	CcSEcCtD
Zalcitabine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	1.7e-05	0.000238	CcSEcCtD
Zalcitabine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	1.7e-05	0.000238	CcSEcCtD
Zalcitabine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	1.7e-05	0.000237	CcSEcCtD
Zalcitabine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	1.7e-05	0.000237	CcSEcCtD
Zalcitabine—Vomiting—Indinavir—acquired immunodeficiency syndrome	1.69e-05	0.000237	CcSEcCtD
Zalcitabine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	1.69e-05	0.000235	CcSEcCtD
Zalcitabine—Rash—Indinavir—acquired immunodeficiency syndrome	1.68e-05	0.000235	CcSEcCtD
Zalcitabine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	1.68e-05	0.000234	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	1.67e-05	0.000234	CcSEcCtD
Zalcitabine—Headache—Indinavir—acquired immunodeficiency syndrome	1.67e-05	0.000233	CcSEcCtD
Zalcitabine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	1.67e-05	0.000233	CcSEcCtD
Zalcitabine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	1.65e-05	0.00023	CcSEcCtD
Zalcitabine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	1.64e-05	0.000229	CcSEcCtD
Zalcitabine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	1.63e-05	0.000227	CcSEcCtD
Zalcitabine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	1.62e-05	0.000226	CcSEcCtD
Zalcitabine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	1.62e-05	0.000226	CcSEcCtD
Zalcitabine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	1.6e-05	0.000224	CcSEcCtD
Zalcitabine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	1.6e-05	0.000223	CcSEcCtD
Zalcitabine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	1.59e-05	0.000222	CcSEcCtD
Zalcitabine—Rash—Efavirenz—acquired immunodeficiency syndrome	1.59e-05	0.000222	CcSEcCtD
Zalcitabine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	1.59e-05	0.000222	CcSEcCtD
Zalcitabine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	1.58e-05	0.000221	CcSEcCtD
Zalcitabine—Headache—Efavirenz—acquired immunodeficiency syndrome	1.58e-05	0.00022	CcSEcCtD
Zalcitabine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	1.58e-05	0.00022	CcSEcCtD
Zalcitabine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	1.54e-05	0.000215	CcSEcCtD
Zalcitabine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	1.53e-05	0.000214	CcSEcCtD
Zalcitabine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	1.52e-05	0.000213	CcSEcCtD
Zalcitabine—Rash—Delavirdine—acquired immunodeficiency syndrome	1.52e-05	0.000212	CcSEcCtD
Zalcitabine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	1.52e-05	0.000212	CcSEcCtD
Zalcitabine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	1.52e-05	0.000212	CcSEcCtD
Zalcitabine—Headache—Delavirdine—acquired immunodeficiency syndrome	1.51e-05	0.000211	CcSEcCtD
Zalcitabine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	1.51e-05	0.00021	CcSEcCtD
Zalcitabine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	1.47e-05	0.000206	CcSEcCtD
Zalcitabine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	1.47e-05	0.000205	CcSEcCtD
Zalcitabine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	1.47e-05	0.000205	CcSEcCtD
Zalcitabine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	1.45e-05	0.000202	CcSEcCtD
Zalcitabine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	1.42e-05	0.000198	CcSEcCtD
Zalcitabine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	1.42e-05	0.000198	CcSEcCtD
Zalcitabine—Rash—Ritonavir—acquired immunodeficiency syndrome	1.4e-05	0.000196	CcSEcCtD
Zalcitabine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	1.4e-05	0.000196	CcSEcCtD
Zalcitabine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	1.4e-05	0.000195	CcSEcCtD
Zalcitabine—Headache—Ritonavir—acquired immunodeficiency syndrome	1.4e-05	0.000195	CcSEcCtD
Zalcitabine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	1.36e-05	0.00019	CcSEcCtD
Zalcitabine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	1.35e-05	0.000189	CcSEcCtD
Zalcitabine—Rash—Saquinavir—acquired immunodeficiency syndrome	1.35e-05	0.000189	CcSEcCtD
Zalcitabine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	1.35e-05	0.000189	CcSEcCtD
Zalcitabine—Headache—Saquinavir—acquired immunodeficiency syndrome	1.34e-05	0.000188	CcSEcCtD
Zalcitabine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.3e-05	0.000182	CcSEcCtD
Zalcitabine—Rash—Lamivudine—acquired immunodeficiency syndrome	1.29e-05	0.00018	CcSEcCtD
Zalcitabine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.29e-05	0.00018	CcSEcCtD
Zalcitabine—Headache—Lamivudine—acquired immunodeficiency syndrome	1.28e-05	0.000179	CcSEcCtD
